COVID-19: Brand-New Study Compares Side Effects Of Pfizer, Moderna Vaccine Recipients

Marco Green
April 10, 2021

The companies are seeking an emergency use authorization from the Food and Drug Administration.

The company received authorization for use in individuals aged 16 and over late previous year.

Upstate Medical University was one of the trial sites for the 12- to 15-year-old age group. But the risks of getting vaccinated - severe reactions remain incredibly rare - far outweigh the risks of Covid-19 infection, he said.

Those who have taken the Moderna COVID-19 vaccine are reporting more side effects than those who got a dose from Pfizer, according to a new study.

In late March they published the results of trials carried out with 2,260 adolescents in the U.S. who the companies said showed "robust anti-body responses".

Researchers of this study say that a greater percentage of participants who received the Moderna vaccine, compared with the Pfizer-BioNTech vaccine, reported reactogenicity; this pattern was more pronounced after the second dose.

The companies said in a statement that they plan to make similar requests of other regulatory authorities worldwide in coming days.

On the first day of the United Kingdom campaign for COVID-19 vaccination, there were reports of two cases of anaphylaxis - a severe, potentially life-threatening allergic reaction - within minutes of administration of the Pfizer/BioNTech mRNA vaccine.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER